Affected investors can now file compensation claims against Dalian Bio-Chem Company Limited (603360) for alleged false statements, with the legal process officially commencing. The announcement was made by securities litigation lawyer Xu Feng from Shanghai Jiucheng Law Firm.
On the evening of April 27, 2026, Dalian Bio-Chem disclosed that it had received a formal investigation notice from the China Securities Regulatory Commission (CSRC). The regulator initiated proceedings against the company due to suspected violations of information disclosure regulations under the Securities Law and Administrative Penalty Law.
Concurrently, Dalian Bio-Chem's board released a statement detailing corrections of prior accounting errors and retrospective adjustments. During its 24th meeting of the fifth board held on April 27, 2026, the company approved a proposal to rectify earlier accounting inaccuracies. This corrective action involves restating financial reports for the 2024 annual report, 2025 first-quarter report, 2025 semi-annual report, and 2025 third-quarter report, complying with relevant accounting standards and disclosure rules.
Attorney Xu Feng indicated that based on comprehensive information, investors who purchased Dalian Bio-Chem shares between April 25, 2025, and April 28, 2026, and sold or held these shares after April 28, 2026, are now eligible to submit claims for losses.
In a separate development, the investor compensation case involving Surfilter Network Technology Co.,Ltd. (300311) is progressing. The second trial for claims represented by Xu Feng is scheduled to be heard at the Guangdong High People's Court on May 26, 2026, following a first-instance favorable ruling for investors. Additionally, on April 29, 2026, the legal team submitted another batch of claims for court acceptance, with ongoing efforts to file subsequent cases and accept new client mandates.
Surfilter Network had previously received an administrative penalty decision on July 18, 2025. Investigations revealed that from 2020 to the first half of 2022, the company artificially inflated revenues by 36.95 million yuan, 48.44 million yuan, and 26.93 million yuan, representing 4.21%, 6.97%, and 10.81% of reported figures for those periods, respectively. Falsified profits amounted to 19.41 million yuan, 37.32 million yuan, and 16.56 million yuan, accounting for 85.93%, 70.03%, and 30.79% of absolute reported values. The company's 2020 annual report, 2021 annual report, and 2022 semi-annual report contained misrepresentations. These inflated revenue figures from 2020 and 2021 were also referenced in a private placement prospectus filed on February 14, 2023.
According to Xu Feng, leveraging prior successful investor rulings, shareholders who acquired Surfilter Network stock between April 28, 2021, and August 10, 2024, and sold or retained shares after August 10, 2024, remain eligible to pursue compensation.
Comments